Current blood biomarkers, such as carcinoembryonic antigen (CEA), in colorectal cancer could improve the use of image-based assessments, but the sensitivity and specificity of these markers are moderate [3–5]. The gene discussed is CEACAM5; the disease is colorectal cancer.